Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.1M | $2.9M | $120,627.00 | $202,670.00 | $701,967.00 | $2.1M |
| Gross profit | $441,095.00 | $535,485.00 | -$204,542.00 | -$74,457.00 | -$2.4M | $1.2M |
| Operating income | — | — | — | — | — | — |
| Net income | -$6.3M | -$28.1M | -$15.2M | -$15.1M | -$49.4M | -$68.2M |
| Diluted EPS | -$0.86 | -$1.69 | -$0.69 | -$0.49 | -$31.77 | -$17.02 |
| Operating cash flow | -$2.7M | -$6.5M | -$6.4M | -$10.5M | -$18.1M | -$25.3M |
| Free cash flow | -$2.8M | -$6.6M | -$6.5M | -$10.6M | -$18.2M | — |
| Gross margin | 41.4% | 18.6% | -169.6% | -36.7% | -348.4% | 58.5% |
| Operating margin | — | — | — | — | — | — |
| Net margin | -590.2% | -977.0% | -12619.9% | -7442.2% | -7038.7% | -3220.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $710,240.00 | $110,213.00 | -$289,218.00 | $42,101.00 | $44,948.00 | $1.5M | $515,443.00 | $786,331.00 |
| Gross profit | $205,712.00 | -$292,186.00 | -$146,730.00 | $20,989.00 | $23,878.00 | $543,142.00 | $650,097.00 | $3.6M |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | -$8.3M | -$11.9M | -$13.5M | -$5.3M | $13.4M | -$33.6M | -$42.7M | -$1.8M |
| Diluted EPS | -$0.16 | -$0.21 | -$31.07 | -$0.08 | $0.09 | — | — | — |
| Operating cash flow | -$5.7M | — | — | -$4.6M | -$1.7M | — | — | -$1.9M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 29.0% | -265.1% | 50.7% | 49.9% | 53.1% | 35.9% | 126.1% | 456.9% |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | -1165.0% | -10823.8% | 4678.7% | -12652.7% | 29756.5% | -2216.8% | -8274.9% | -232.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-13 | Rudy Mitchell Austin | Buy | 9,000 | $1.21 | $10,890.00 | filing |
| 2026-07-10 | Rudy Mitchell Austin | Buy | 1,000 | $1.21 | $1,210.00 | filing |
| 2026-07-02 | Rudy Mitchell Austin | Buy | 11,659 | $1.47 | $17,138.73 | filing |
| 2026-06-22 | Rudy Mitchell Austin | Buy | 2,500 | $1.57 | $3,925.00 | filing |
| 2026-06-22 | Rudy Mitchell Austin | Buy | 2,500 | $1.56 | $3,900.00 | filing |
| 2026-06-22 | Rudy Mitchell Austin | Buy | 2,500 | $1.55 | $3,875.00 | filing |
| 2026-06-16 | Rudy Mitchell Austin | Buy | 2,500 | $1.32 | $3,300.00 | filing |
| 2026-06-10 | Rudy Mitchell Austin | Buy | 12,000 | $1.37 | $16,440.00 | filing |
| 2026-04-09 | Rudy Mitchell Austin | Buy | 31,055 | $2.82 | $87,575.10 | filing |
Latest 9 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.